Inhibikase Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45719W2052
USD
1.58
-0.37 (-18.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryInhibikase Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-18.97%
-0.51%
1W
-22.17%
-1.37%
1M
-21%
0.35%
YTD
-51.38%
0.54%
1Y
-3.07%
13.99%
3Y
-72.28%
66.39%
5Y
%
77.77%
10Y
%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.6%
0%
-20.6%
6 Months
-50.62%
0%
-50.62%
1 Year
-3.07%
0%
-3.07%
2 Years
-61.52%
0%
-61.52%
3 Years
-72.28%
0%
-72.28%
4 Years
-95.73%
0%
-95.73%
5 Years
0%
0%
0.0%

Inhibikase Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary